Virology & Mycology
Open Access

Cytomegalovirus (CMV) Histology and Pathology: Understanding the Virus's Impact on Human Cells

Masaya Flores^{* *}Correspondence: Masaya Flores, Department of Medicine, University of Tennessee Health and Science, Baltimore, United States of America, Email:

Author info »

Description

Cytomegalovirus (CMV) is a ubiquitous herpesvirus that infects a significant portion of the global population. While CMV typically causes asymptomatic infections in healthy individuals, it can have severe consequences in immunocompromised individuals, such as those with Human Immunodeficiency Virus/ Acquired Immunodeficiency Syndrome (HIV/AIDS) or undergoing organ transplantation. This article explains the histology and pathology of CMV, exploring how the virus interacts with human cells and the characteristic changes it induces.

CMV structure and replication

CMV is a large, double-stranded Deoxyribonucleic Acid (DNA) virus that belongs to the herpesvirus family. The virus has a complex structure, comprising an outer envelope and an inner capsid. The viral genome is approximately 240 kb in size and contains over 150 genes.

CMV replication occurs in three stages are adsorption, penetration and maturation. During adsorption, the virus binds to host cells via specific receptors. Penetration involves the entry of the virus into the host cell through fusion of the viral envelope with the host cell membrane. Maturation occurs in the cytoplasm, where the viral genome is transcribed and translated into new viral particles.

CMV histology

The histological changes induced by CMV infection are characterized by:

Nuclear enlargement: Infected cells display enlarged nuclei, often referred to as owl's eye cells due to their characteristic morphology.

Cytoplasmic vacuolation: Infected cells exhibit vacuoles filled with viral particles, which can lead to cellular swelling.

Giant cell formation: CMV infection can cause the formation of giant cells, which are large, multinucleated cells that arise from the fusion of infected cells.

Inflammation: CMV infection can induce an inflammatory response, characterized by infiltrates of immune cells, such as lymphocytes and macrophages.

CMV pathology

The pathology of CMV infection is diverse and can affect various organs and tissues. The most common sites of CMV infection include:

Salivary glands: CMV infection can cause salivary gland enlargement and inflammation.

Adrenal glands: CMV infection can lead to adrenal insufficiency due to destruction of adrenal tissue.

Liver: CMV infection can cause hepatitis, liver failure and cirrhosis.

Brain: CMV infection can cause encephalitis, meningitis and cognitive impairment.

Eye: CMV infection can cause retinitis, uveitis and vision loss.

Clinical manifestations

CMV infection can manifest clinically in various ways, depending on the severity of the infection and the individual's immune status. Common symptoms include:

Fever: Elevated body temperature is a common symptom of CMV infection.

Malaise: Fatigue, weakness and general feeling of illness.

Hepatomegaly: Enlargement of the liver.

Neurological symptoms: Headache, confusion, seizures and personality changes.

Diagnosis and treatment

The diagnosis of CMV infection is typically made through laboratory testing, including:

Serology: Detecting antibodies against CMV in serum.

Molecular testing: Detecting CMV DNA or RNA in blood or tissue samples.

Histopathology: Examining tissue samples for characteristic histological changes.

Treatment for CMV infection usually involves antiviral therapy with medications such as ganciclovir or valganciclovir. In severe cases, immunoglobulin therapy may be necessary to boost the immune response.

Conclusion

Cytomegalovirus histology and pathology reveal a complex between the virus and human cells, leading to characteristic changes in infected cells and tissues. Understanding these changes is essential for diagnosing and treating CMV infections, particularly in immunocompromised individuals where the virus can have severe consequences. Further study into the molecular mechanisms underlying CMV pathogenesis may lead to the development of more effective therapies and ultimately improve patient outcomes.